AVE 0.00% 0.2¢ avecho biotechnology limited

eureka report, page-16

  1. 5,322 Posts.
    Instanac revenue to POH would be more realistically pegged at few hundred thous imho- margins in India are miniscule- plus I suspect the Instanac product wont be left in the market against Novartis TPM very long
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.